Opinion|Videos|December 12, 2024
Safety, Efficacy, and Treatment Adherence in Young Patients With Vitiligo
Author(s)Karan Lal, DO, MS, FAAD
Karan Lal, DO, MS, FAAD, discusses how to balance safety and efficacy considerations while promoting treatment adherence in young vitiligo patients, focusing on the unique challenges and monitoring requirements for this vulnerable population.
Advertisement
Episodes in this series
Advertisement
Related to this article
Dermatology clinicians at a Case-Based Roundtable in Austin, Texas, discussed real-world strategies for sequencing topical therapy, phototherapy, and ruxolitinib cream across pediatric and adult vitiligo cases.
In TRANQUILLO 2, 21.86% of patients taking ritlecitinib 100 mg achieved F-VASI75 at week 52 vs 2.40% with placebo, according to data presented at EADV 2026.
Advertisement
Advertisement
Trending on Dermatology Times
1
First-in-Class Oral PKM2 Modulator Shows Early Efficacy in Atopic Dermatitis
2
Alopecia Areata Is a Medical Disease: Treatment Options and Defining Severity
3
Galderma to Acquire ZO Skin Health for $1.5 Billion
4
Chronic Hand Eczema Linked to Lost Productivity and Lower Quality of Life
5